Latest Taro Pharmaceutical Industries News & Updates

See the latest news and media coverage for Taro. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Taro Pharmaceutical Industries (Taro)

Generic pharmaceutical and consumer healthcare company

taro.com
Headquarters
United States
Company type
Public company
Number of employees
1,200–5,000
Industry
Pharmaceuticals

Last updated

Latest news about Taro Pharmaceutical Industries (Taro)

In short: Taro merged with Sun Pharma and faced recalls, lawsuits, and new generic product launches.

Company announcements

Taro

Taro announces USFDA approval for generic Depo-Testosterone Injection

This approval allows Taro to market a generic alternative to Depo-Testosterone Injection.

Unlock all announcements with a

Media coverage

Ad Hoc News

The Taro stock is sold off after cash takeover

The Taro stock has disappeared from the exchange at $32.25 per share following a cash takeover. The pharmaceutical company, which focuses on dermatology, is being fully integrated, while...

Pharmaceutical Executive

Taro Appoints Interim CEO | PharmExec

Taro Pharmaceutical Industries (Hawthorne, NY) announced that its Board of Directors has appointed Mr. Abhay Gandhi to the position of Interim Chief Executive Officer, effective...

Unlock all articles with a

Never miss news about Taro

Track Taro and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.